LARRY GLASS

Very kind of you to provide those links!

The adenosylcobalamin (dibencozide b12) study was published in Cell Research (2019): “Vitamin B12 Modulates Parkinson’s Disease LRRK2 Kinase Activity Through Allosteric Regulation and Confers Neuroprotection.”  The best explanatory article about the study that I have read  was published in The Science of Parkinson’s (3/22/19):  “AdoCbl + LRRK2 =…[Read more]

I cut the pills in half with a pill cutter from CVS.  Incidentally, the serving info on each of the B12 bottles says that 3000 mcg is 125,000% of the recommended “daily value.”  The dosage amounts and intake variations and schedule kind of evolved.  Taking the B12’s sublingually gets the B12 directly into the blood circulation, avoiding the di…[Read more]

I use Country Life brand, Methyl B12 3000 mcg lozenges (1/2 totally dissolved sublingual, and 1/2 swallowed before breakfast) and Active B12 Dibencozide 3000 mcg lozenges (1/2 totally dissolved sublingual before dinner, and 1/2 totally dissolved sublingual before bedtime with 1/2 swallowed).

What I just said about cane sugar might be confusing.  To clarify, I became super-sensitive to cane sugar as a result of taking dibencozide B12.

I was diagnosed with Parkinson’s in 2013.  In about April, 2019, on Parkinson’s News Today I saw a summary of a study dealing with my LRRK2-G2019S mutation.  The study basically reported experiments on worms, flied and mice that  were genetically engineered to have that specific mutation.  The researchers found that administration of the ade…[Read more]

I read your note with great interest.  I have been experimenting successfully with the two active B-12 vitamins you mention.  I summarized this in a letter to my neurologist at the beginning of May, that I would provide you, if I only understood how to attach it to this response.  Is there a way to do that?